Simultaneous LC–MS/MS quantitation of acetaminophen and its glucuronide and sulfate metabolites in human dried blood spot samples collected by subjects in a pilot clinical study

References

• 1  Li W, Tse FLS. Dried blood spot sampling in combination with LC–MS/MS for quantitative analysis of small molecules. Biomed. Chromatogr.24(1),49–65 (2010).
  MedlineGoogle Scholar
• 2  Johannessen A. Dried blood spots in HIV monitoring: applications in resource-limited settings. Bioanalysis2(11),1893–1908 (2010).
  CASGoogle Scholar
• 3  Johannessen A, Trøseid M, Calmy A. Dried blood spots can expand access to virological monitoring of HIV treatment in resource-limited settings. J. Antimicrob. Chemother.64(6),1126–1129 (2009).
  Medline CASGoogle Scholar
• 4  Cheung CY, van der Heijden J, Hoogtanders K et al. Dried blood spot measurement: application in tacrolimus monitoring using limited sampling strategy and abbreviated AUC estimation. Transplant. International21(2),140–145 (2008).
  Medline CASGoogle Scholar
• 5  Wilhelm AJ, den Burger JC, Vos RM, Chahbouni A, Sinjewel A. Analysis of cyclosporin A in dried blood spots using liquid chromatography tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.877(14–15),1595–1598 (2009).
  Medline CASGoogle Scholar
• 6  van der Heijden J, de Beer Y, Hoogtanders K et al. Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometry. J. Pharm. Biomed. Anal.50(4),664–670 (2009).
  Medline CASGoogle Scholar
• 7  Hoogtanders K, van der Heijden J, Christiaans M, van de Plas A, van Hooff J, Stolk L. Dried blood spot measurement of tacrolimus is promising for patient monitoring. Transplantation83(2),237–238 (2007).
  Medline CASGoogle Scholar
• 8  Hoogtanders K, van der Heijden J, Christiaans M, Edelbroek P, van Hooff JP, Stolk LM. Therapeutic drug monitoring of tacrolimus with the dried blood spot method. J. Pharm. Biomed. Anal.44(3),658–664 (2007).
  Medline CASGoogle Scholar
• 9  Moller P, Sindet-Pedersen S, Petersen C, Juhl G, Dillenschneider A, Skoglund L. Onset of acetaminophen analgesia: comparison of oral and intravenous routes after third molar surgery. Br. J. Anaesthesia94(5),642–648 (2005).
  Medline CASGoogle Scholar
• 10  Acetaminophen. Physicians’ Desk Reference (63rd Edition). Thomson Reuters, NJ, USA 1915–1916 (2009).
  Google Scholar
• 11  Hendrickson RG, Bizovi KE. Acetaminophen. In: Goldfrank’s Toxicologic Emergencies. Nelson LH, Flomenbaum N, Goldfrank LR et al. (Eds). 525, McGraw-Hill, NY, USA (2006).
  Google Scholar
• 12  Spooner N, Ramakrishnan Y, Barfield M, Dewit O, Miller S. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations. Bioanalysis2(8),1515–1522 (2010).
  CASGoogle Scholar
• 13  Spooner N, Lad R, Barfield M. Dried blood spots as a sample collection technique for the determination of pharmacokinetics in clinical studies: considerations for the validation of a quantitative bioanalytical method. Anal. Chem.81(4),1557–1563 (2009).
  Medline CASGoogle Scholar
• 14  Barfield M, Spooner N, Lad R, Parry S, Fowles S. Application of dried blood spots combined with HPLC–MS/MS for the quantification of acetaminophen in toxicokinetic studies. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.870(1),32–37 (2008).
  Medline CASGoogle Scholar
• 15  Zhao L, Pickering G. Paracetamol metabolism and related genetic differences. Drug Metab. Rev.43(1),41–52 (2011).
  Medline CASGoogle Scholar
• 16  Li W, Zhang J, Tse FL. Strategies in quantitative LC–MS/MS analysis of unstable small molecules in biological matrices. Biomed. Chromatogr.25(1–2),258–277 (2011).
  MedlineGoogle Scholar
• 17  Denniff P, Spooner N. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis2(8),1385–1395 (2010). Erratum in: Bioanalysis3(7),818 (2011).
  CASGoogle Scholar
• 18  European Medicines Agency, Committee for Medicinal Products for Human Use (CHMP), Guidance on the Validation of Bioanalytical Methods, London (2011).
  Google Scholar
• 19  US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products – General Considerations. (2003).
  Google Scholar
• 20  European Medicines Agency Committee for Medicinal Products for Human Use. Guidance on the Investigation of Bioequivalence. (2010).
  Google Scholar
• 21  Yin OQ, Tomlinson B, Chow AH, Chow MS. Pharmacokinetics of acetaminophen in Hong Kong Chinese subjects. Int. J. Pharm.222(2),305–308 (2001).
  Medline CASGoogle Scholar
• 22  Rawlins MD, Henderson DB, Hijab AR. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur. J. Clin. Pharmacol.11(4),283–286 (1977).
  Medline CASGoogle Scholar
• 23  Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br. J. Clin. Pharmacol.10(Suppl. 2),291S–298S (1980).
  MedlineGoogle Scholar
• 24  Forrest JA, Clements JA, Prescott LF. Clinical pharmacokinetics of paracetamol. Clin. Pharmacokinet.7(2),93–107 (1982).
  Medline CASGoogle Scholar
• 25  Portoles A, Puerro M, Terleira A et al. A new high-absorption-rate paracetamol 500-mg formulation: a comparative bioavailability study in healthy volunteers. Curr. Ther. Res.64(7),401–411 (2003).
  Medline CASGoogle Scholar
• 101  Tylenol^®. www.tylenolprofessional.com/index.html
  Google Scholar
• 102  FTA Elute Technology. www.whatman.com/FTAElute.aspx
  Google Scholar
• 103  US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Guidance for Industry: Bioanalytical Method Validation, May, 2001. www.fda.gov/CDER/GUIDANCE/4252fnl.htm
  Google Scholar